Strengths of the present meta-analysis are the inclusion of all CVOTs published by 10 December 2021, the very large number of participants, the high quality of the trials which minimizes the risk of bias, and the absence of significant heterogeneity in most analyses, which ranged from absent to low or moderate
What sets it apart from many competitors is the range of options it offers
Effects of Liraglutide on Appetite, Food Preoccupation, and Food Liking: Results of a Randomized Controlled Trial
In a 2018 analysis of clinical trial data, several researchers working with Novo Nordisk, the drugmaker for Ozempic and Wegovy, found that the drugs were safe and effective in adults over age 65, but noted that older adults reported discontinuation due to gastrointestinal issues at a higher rate than younger participants did
At Restore, our GLP-1 Plans are designed to improve metabolic health and support your longevity
It is approved for cardiovascular risk reduction and is one of the few GLP1 agents approved for children aged 10 and above
